Abstract: A pharmaceutical composition comprises a drug-carrier system having a small-molecule drug of low water solubility such as one or more small molecule integrin agonist adjuvants in a substantially non-aqueous carrier composition that comprises at least one phospholipid, at least one neutral lipid, and at least one pharmaceutically acceptable solubilizing agent. The drug-carrier system, when mixed with an aqueous phase, typically forms a non-gelling, substantially non-transparent liquid dispersion. The composition is suitable for administration by a suitable route, e.g., orally, to a subject in need thereof.

Abstract: A method for identifying a completed lap at a device is disclosed. An example method includes retrieving or defining lap initiation data that can include an initiation location and an initiation orientation. The method also includes retrieving or defining a location variance threshold for the initiation location and an orientation variance threshold for the initiation orientation. The method further includes determining, by a position determining module of the device, a first location of the device associated with a first time. The method also includes determining, by an orientation determining module of the device, a first orientation of the device associated with the first time. The method also includes identifying a lap as completed upon determining that the first location of the device is within the location variance threshold of the initiation location and that the first orientation of the device is within the orientation variance threshold of the initiation orientation.

Abstract: A layered catalyst structure for purifying an exhaust gas stream includes a catalyst support and a rhodium catalyst layer including an atomic dispersion of rhodium ions and/or rhodium atoms adsorbed on an exterior surface of the catalyst support. The catalyst support includes an alumina substrate, a first ceria layer disposed on and extending substantially continuously over the alumina substrate, and a second colloidal ceria layer formed directly on the first ceria layer over the alumina substrate.

Abstract: Methods, apparatus, systems, and articles of manufacture are disclosed to generate synthetic respondent level data. Example apparatus disclosed herein include means for generating a synthetic panel corresponding to a duration of time, the means for generating the synthetic panel to: generate a transition matrix corresponding to a first sub-duration of the duration of time and a second sub-duration of the duration of time; generate, based on the transition matrix, a plurality of synthetic panelists and associated viewing data; remove first ones of the synthetic panelists associated with one or more weights that do not satisfy a threshold to generate the synthetic panel corresponding to the duration of time, the synthetic panel representative of audiences of media presented by a plurality of media devices during the duration of time; and generate synthetic respondent level data based on the viewing data associated with remaining second ones of the synthetic panelists.

Abstract: A paperboard structure includes a paperboard substrate having a first surface and an opposed second surface. A biopolymer coating is applied by extrusion or co-extrusion to at least one of the first surface and the second surface. The biopolymer coating includes an inorganic melt curtain stabilizer, a polylactide resin having a melt flow index, and an organic polymeric chain extender.

Abstract: A system including a lithium-ion battery is provided. The system includes two electrodes, which include an anode and a cathode. The system further includes an electrolyte and a planar separator disposed between the anode and the cathode. The planar separator includes a first planar face, a second planar face, a layer of porous ceramic material coating the first planar face, and lithium deposited upon the layer of porous ceramic material. The lithium is in contact with one of the two electrodes.

Abstract: A controlled release fill composition for use in soft or hard capsules, soft- or hard-shell capsules encapsulating controlled release fill compositions, a method of producing a softgel capsule with a controlled release fill composition encapsulated in the soft gel capsule shell. The controlled release fill composition includes an active pharmaceutical ingredient; polyethylene oxide having a number average molecule weight of from 0.05 M daltons to 15 M daltons; and at least one of water or a hydrophilic carrier having a number average molecule weight of from 200 daltons to 5000 daltons. Also, in the controlled release fill composition either the polyethylene oxide is present in an amount of at least 21.5 wt. %, based on a total weight of the controlled release fill composition, or the hydrophilic carrier is present in an amount up to 65 wt. %, based on a total weight of the controlled release fill composition.

Abstract: Hemp-based absorbent articles are disclosed. The absorbent article can be a tampon or pad for feminine hygiene. The absorbent article can be flushable or compostable. In one example, the absorbent article is a flushable tampon for feminine hygiene having a nonwoven material comprising hemp with a hemp fiber length in a range of about 8 mm to about 15 mm. The nonwoven material can include an absorbent ribbon, a string, and an overwrap.

Abstract: An example of a memory device may comprise NAND media with a plurality of decks, and circuitry coupled to the NAND media to control access to a superblock of memory cells aligned along a pillar of the NAND media, wherein the superblock includes at least a first block that corresponds to memory cells aligned along the pillar in a first deck of the plurality of decks and a second block that corresponds to memory cells aligned along the pillar in a second deck of the plurality of decks, configure the NAND media in a first program mode for the first block of the superblock, and configure the NAND media in a second program mode for the second block of the superblock. Other examples are disclosed and claimed.

Abstract: The disclosed embodiments provide systems, methods, and techniques for managing merchandising cards. A merchandising card may be, for example, a gift card, loyalty card, or the like. Consistent disclosed embodiments, a system for managing merchandising cards may include one or more memory devices storing instructions and one or more processors configured to acquire, from a device over a network, a plurality of locations associated with the device, the device locations being acquired at different instances in time within a predetermined period of time. Additionally, the one or more processors may be configured to calculate an overall merchant confidence rating for a merchant using the device locations. Further, the one or more processors may be configured to, based on the overall merchant confidence rating, determine that the merchant matches a merchant that is associated with merchandising card, and send a reminder a user of the device.

Abstract: Millimeter wave access system and method for device-to-device communications (D2D) are described.

Abstract: Disclosed herein are apparatus for a cooler device includes a manifold constructed at least partially of silicon oxide. The manifold includes an array of inlet channels and an array of outlet channels. Each inlet channel has a first depth. The array of outlet channels are interlaced with the array of inlet channels, Each outlet channel has a second depth that is larger than the first depth. Each of the array of outlet channels has a pair of sidewalls separating each outlet channel from adjacent inlet channels of the array of inlet channels.

Abstract: A tourniquet for applying pressure to a limb to stop the flow of blood is disclosed. The tourniquet includes a plate, a first band and a second band. The first band draws through the plate. The first band includes a tensioning member. The second band positions within the first band such that one end of the second band connects to the first band and the other end of the second band connects to the tensioning member. The first band receives the limb of the user while the plate remains on the limb. The tensioning member operates to draw the second band towards the tensioning member allowing the first band to put pressure on the limb and stop the flow of blood. In one embodiment, the plate connects to a holster. Further, the plate suspends from a waist strap wrapped around a waist of the user.

Abstract: A base station central unit control plane (CU-CP) receives, from a base station central unit user plane (CU-UP), an indication of a size of downlink data for a wireless device. The base station CU-CP transmits, to a base station distributed unit (DU) and base on the size of the downlink data, a first paging message for the wireless device indicating a small data transmission (SDT) procedure of the wireless device.

Abstract: Instruments and components for improving the accuracy of resection of the proximal tibia in a kinematic alignment total knee arthroplasty (“TKA”). Instruments include an adjustable double tibial stylus instrument comprising: a first wide convex stylus tip and a second wide convex stylus tip at a second distal end of the second stylus. The wide convex stylus tips may be fixed components of the adjustable double stylus instrument, or the wide convex stylus tips may be detachable.

Abstract: Novel neuroprotective preparations of hemp oil and magnesium are disclosed herein. Antioxidant and anti-inflammatory activity of hemp oil (containing a broad-spectrum of beneficial phytochemicals) are combined with magnesium and has been found to reduce oxidative stress, upregulation of antioxidant enzyme systems, and the mitigation of NMDA-receptor hyperactivity. The synergistic effects of hemp oil and bioavailable magnesium are utilized to improve cognitive function, mood, stress tolerance, and reduce oxidative stress and inflammation. A highly-efficacious, lipophilic, trans-mucosal, delivery system is included to provide exceptional bioavailability of a palatable and convenient intra-oral, or topical, anti-inflammatory, neurotrophic, and neuroprotective preparation. Additionally, methods of use are described, allowing for effective, safe, and convenient use for general (public) and clinical use, in both humans and animals.

Abstract: An assembly for a vehicle includes a vehicle roof and a panel rotatably connected to the vehicle roof. The panel is rotatable away from the vehicle roof from a stowed position to a deployed position. The assembly includes an airbag supported on the panel. The airbag is inflatable from the panel in a vehicle-forward direction when the panel is in the deployed position.

Abstract: A system and method for operating a vehicle to mitigate vision obstructions includes collecting data on potential vision obstructions in a sightline of an operator of a vehicle, determining, based on the data, that a vision obstruction has occurred or is about to occur, and actuating a corrective measure in the vehicle. Collected data may include camera data from inside the vehicle and estimated environmental conditions, and the collected data may be used to disable the ADAS based on a detected or impending vision obstruction.

Abstract: Systems and methods are described herein that utilize a decentralized control panel architecture to monitor or control components or (sub-)systems of an aircraft or other vehicle. A controller can be used to receive information from multiple input sources and send a command to one or more output devices based on the received information. The received information may be of different types or formats that can be read by the controller. The controller may cause a visual or physical change to an actuator based on the command. One or more control panel entities can be communicatively coupled with the controller and used to access information about one or more (sub-)systems of the vehicle and send commands where appropriate.

Abstract: Disclosed is a composition comprising difluoromethane (R-32), 2,3,3,3-tetrafluoropropene (R-1234yf), and isobutane (R-600a). A refrigeration system, including a hermetic compressor and a refrigerant composition. The refrigerant composition includes difluoromethane (R-32), 2,3,3,3-tetrafluoropropene (R-1234yf), and isobutane (R-600a).